| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/04/2008 | US7339033 Pro1481 |
| 03/04/2008 | US7339031 Cancer therapeutics; inhibits protein synthesis on ribosomes |
| 03/04/2008 | US7339029 Sperm-specific cation channel, CatSper2, and uses therefor |
| 03/04/2008 | US7339024 PRO1772 polypeptides |
| 03/04/2008 | US7338931 Administering a hyaluronic acid and an insulin for treating diabetes; structure compacted due to the passing of the structure over its point of collapse with buried polar groups and a minimum size; the hyaluronic acid surrounds the insulin |
| 03/04/2008 | US7338929 Cancer immunotherapy |
| 03/04/2008 | US7338794 Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant and vaccine accelerant |
| 03/04/2008 | US7338786 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 03/04/2008 | US7338772 RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate |
| 03/04/2008 | US7338770 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
| 03/04/2008 | US7338676 Pine cone extracts and uses thereof |
| 03/04/2008 | US7338672 Administering Leucojum aestivum plant extract containing galanthamine for improving Estrogen-deficiency related cognitive dysfunction |
| 03/04/2008 | US7338662 Recombinant poxvirus expressing homologous genes inserted into the foxviral genome |
| 03/04/2008 | US7338661 Infectious bursal disease virus antigenic isolates and vaccines |
| 03/04/2008 | US7338660 Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 |
| 03/04/2008 | US7338659 Reducing immunogenicities of immunoglobulins by framework-patching |
| 03/04/2008 | US7338658 Chimeric antibody specific to human CD4 which comprises the variable heavy and light chain sequences of an Old World monkey monoclonal antibody produced against human CD4 and human constant heavy and light domain sequences |
| 03/01/2008 | CA2598060A1 Methods and compositions for the treatment and prevention of cancer |
| 03/01/2008 | CA2597840A1 Methods and compositions for the treatment and prevention of cancer |
| 02/28/2008 | WO2008025031A1 Treatment of graft-versus-host disease |
| 02/28/2008 | WO2008025020A2 Cd30 binding agents and uses thereof |
| 02/28/2008 | WO2008024919A2 Interferon antagonists, antibodies thereto, and associated methods of use |
| 02/28/2008 | WO2008024879A1 Use of tetanus toxin to amplify inadequate voluntary muscle contraction or to improve muscle tone in an animal actively vaccinated against the toxin and a regimen for treatment |
| 02/28/2008 | WO2008024518A2 Hcv fusion polypeptides |
| 02/28/2008 | WO2008024300A1 SEMAPHORIN 7A PLAYS A CRITICAL ROLE IN TGF-β1-INDUCED PULMONARY FIBROSIS AND ALVEOLAR DESTRUCTION |
| 02/28/2008 | WO2008024299A2 Combination with bis(thiohydrazide amides) for treating cancer |
| 02/28/2008 | WO2008024075A1 Modulators of candida hyphal morphogenesis and uses thereof |
| 02/28/2008 | WO2008023947A1 A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma |
| 02/28/2008 | WO2008023946A1 A pharmaceutical composition for treating lung cancer, a method for inhibiting growth or invasion of lung cancer and a method for treating lung cancer |
| 02/28/2008 | WO2008023453A1 Edwardsiella disease in fish and vaccine for streptococcal disease |
| 02/28/2008 | WO2008023233A1 Formulations for antigen-specific tolerance induction |
| 02/28/2008 | WO2008022746A1 Tumor therapy with an anti-vegf antibody |
| 02/28/2008 | WO2008022472A1 Pharmaceutical composition |
| 02/28/2008 | WO2008022401A1 Recombinant hcv e2 glycoprotein |
| 02/28/2008 | WO2008022390A1 Anti-c5ar antibodies with improved properties |
| 02/28/2008 | WO2008006235A3 Scfv antibodies which pass epithelial and/or endothelial layers |
| 02/28/2008 | WO2008000789A3 Pharmaceutical compositions containing monoclonal anti idiotypic anti-ca-125 antibody and aluminium derivatives |
| 02/28/2008 | WO2007147623A3 A novel target in the treatment of cytokine release syndrome |
| 02/28/2008 | WO2007147529A3 Recombinant viral vaccine |
| 02/28/2008 | WO2007145862A3 Extending survival of cancer patients with elevated levels of egf or tgf-alpha |
| 02/28/2008 | WO2007137586A3 Random insertion of peptides |
| 02/28/2008 | WO2007128526A3 Combination comprising a vegf inhibitor and a serine protease for treating neovascular diseases |
| 02/28/2008 | WO2007126788A3 Methods and compositions for the treatment and prevention of viral infection |
| 02/28/2008 | WO2007122392A8 Composition comprising a cytotoxic t-cell - inducing adjuvant |
| 02/28/2008 | WO2007110678A3 Neutralizing antibodies and methods of use thereof |
| 02/28/2008 | WO2007092792A3 Yeast-based vaccine for inducing an immune response |
| 02/28/2008 | WO2007039192A3 Compositions and methods for treating tumors presenting survivin antigens |
| 02/28/2008 | WO2001070932A3 Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife |
| 02/28/2008 | US20080051690 Combination Therapy for Preventing or Treating Alzheimer's Disease, and Kit Therefor |
| 02/28/2008 | US20080051349 Peptide antagonists of zonulin and methods for use of the same |
| 02/28/2008 | US20080051344 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 02/28/2008 | US20080051328 Novel Muscle Growth Regulator |
| 02/28/2008 | US20080050406 Modified Dermatophagoides pteronyssinus allergen Der p 5 protein which inhibits immunoglobulin E (IgE) binding when exposed again to the antigen; treating allergies |
| 02/28/2008 | US20080050405 Ringworm Vaccine |
| 02/28/2008 | US20080050404 Pressure Sore Treatment |
| 02/28/2008 | US20080050403 Production of viruses, viral isolates and vaccines |
| 02/28/2008 | US20080050402 comprising replacements in the influenza nonstructural 1 (NS1) polypeptide, that interferes with viral replication and phosphatidylinositol 3-kinase activation, used for treating and preventing influenza virus infection |
| 02/28/2008 | US20080050401 Rescue of Influenza Virus |
| 02/28/2008 | US20080050399 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/28/2008 | US20080050398 Composition Comprising Beta-Defensin 2 |
| 02/28/2008 | US20080050397 Multiple antigenic agents and methods for using the same |
| 02/28/2008 | US20080050396 useful in vaccine compositions for treatment of cancer; human major histocompatibility complex (MHC) Class I restricted peptides; kits |
| 02/28/2008 | US20080050395 Methods for preparing and delivering adjuvant compositions |
| 02/28/2008 | US20080050394 System and device for medically treating an individual |
| 02/28/2008 | US20080050393 Novel nucleic acids and polypeptides |
| 02/28/2008 | US20080050392 Administration of an activated form of ultra-low doses of antibodies to an antigen, obtained using homeopathic techniques; drug dependence/drug withdrawal; side effect reduction |
| 02/28/2008 | US20080050391 Method for Treating Autoimmune Diseases With Antibodies |
| 02/28/2008 | US20080050390 Administration of gamma globulins to treat metastatic melanoma |
| 02/28/2008 | US20080050389 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
| 02/28/2008 | US20080050388 Specified complementary determining region (CRD) amino acid sequences; specific binding activity for a cryptic collagen epitope; angiogenesis inhibition, antimetastasis, and tumor-targeted therapy uses |
| 02/28/2008 | US20080050387 Non-Androgen Dependent Roles for Androgen Receptor and Non-Androgen Related Inhibitors of Androgen Receptor |
| 02/28/2008 | US20080050386 Novel proteins, gene encoding the same and method of utilization thereof |
| 02/28/2008 | US20080050385 Tumor therapy with an anti-vegf antibody |
| 02/28/2008 | US20080050384 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 02/28/2008 | US20080050383 Immunotherapy for clearing pathological tau conformers |
| 02/28/2008 | US20080050382 Granulysin and uses thereof |
| 02/28/2008 | US20080050381 Antihuman Baff Antibody |
| 02/28/2008 | US20080050380 Glycoprotein VI and uses thereof |
| 02/28/2008 | US20080050379 Cancer gene determination and therapeutic screening using signature gene sets |
| 02/28/2008 | US20080050378 A ribonucleotide sequence corresponding to a gene KIF11 target sequence, where the antisense strand comprises a ribonucleotide sequence complementary to the sense strand; sense/anntisense strands hybridize to form double-stranded molecule which inhibits cell expression of KIf11 (SEQ ID NO: 34) |
| 02/28/2008 | US20080050377 consensus sequences and specific sequences for antibodies that specifically bind to STOP-1; angiogenesis and vasculogenesis; antitumor agents |
| 02/28/2008 | US20080050375 Modulators to transforming growth factors; for disorders related to proliferation and differentiation, migration, apoptosis, embryonic development, extracellular matrix formation, bone development, wound healing, hematopoiesis, and immune and inflammatory responses |
| 02/28/2008 | US20080050374 Immunoglobulin fusion for prevention and treatment of cell proliferative disorders |
| 02/28/2008 | US20080050373 Treatment with anti-erbb2 antibodies |
| 02/28/2008 | US20080050372 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis |
| 02/28/2008 | US20080050371 Comprises immunoglobulin for treating and preventing inflammation, thrombocytopenia and/or autoimmune hemolytic anemia |
| 02/28/2008 | US20080050370 Stabilized polypeptide compositions |
| 02/28/2008 | US20080050369 Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cells |
| 02/28/2008 | US20080050368 Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 02/28/2008 | US20080050367 Humanized antibodies that recognize beta amyloid peptide |
| 02/28/2008 | US20080050366 Neutralizing antibodies and methods of use thereof |
| 02/28/2008 | US20080050365 Anti-Hiv Antibody |
| 02/28/2008 | US20080050363 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 02/28/2008 | US20080050362 Methods of Inhibiting Tumor Cell Aggressiveness Using The Microenvironment of Human Embryonic Stem Cells |
| 02/28/2008 | US20080050360 Method of treating a pathological syndrome and a pharmaceutical agent |
| 02/28/2008 | US20080050358 Identification of Snps Associated with Hyperlipidemia, Dyslipidemia and Defective Carbohydrate Metabolism |
| 02/28/2008 | US20080050357 Systems and Methods for Antibody Engineering |
| 02/28/2008 | US20080050340 Cd40 agonist antibody /type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity |
| 02/28/2008 | US20080050337 Method for using calcium-sensitive potassium channel agonist for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 02/28/2008 | US20080050315 Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1) |